These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27569996)

  • 21. Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2).
    Soler DC; Kerstetter-Fogle A; Young AB; Rayman P; Finke JH; Debanne SM; Cooper KD; Barnholtz-Sloan J; Sloan AE; McCormick TS
    Mol Immunol; 2022 Feb; 142():1-10. PubMed ID: 34953280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
    Chen J; Zhou JH; Ball ED
    Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.
    Yaddanapudi K; Rendon BE; Lamont G; Kim EJ; Al Rayyan N; Richie J; Albeituni S; Waigel S; Wise A; Mitchell RA
    Cancer Immunol Res; 2016 Feb; 4(2):101-12. PubMed ID: 26603621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
    Braster R; O'Toole T; van Egmond M
    Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
    Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.
    OuYang LY; Wu XJ; Ye SB; Zhang RX; Li ZL; Liao W; Pan ZZ; Zheng LM; Zhang XS; Wang Z; Li Q; Ma G; Li J
    J Transl Med; 2015 Feb; 13():47. PubMed ID: 25638150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.
    Albeituni SH; Ding C; Liu M; Hu X; Luo F; Kloecker G; Bousamra M; Zhang HG; Yan J
    J Immunol; 2016 Mar; 196(5):2167-80. PubMed ID: 26810222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells.
    Younos I; Donkor M; Hoke T; Dafferner A; Samson H; Westphal S; Talmadge J
    Int Immunopharmacol; 2011 Jul; 11(7):816-26. PubMed ID: 21376153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
    Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
    Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression.
    Mei S; Xin J; Liu Y; Zhang Y; Liang X; Su X; Yan H; Huang Y; Yang R
    PLoS One; 2015; 10(8):e0135867. PubMed ID: 26285119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD66b
    Horzum U; Yoyen-Ermis D; Taskiran EZ; Yilmaz KB; Hamaloglu E; Karakoc D; Esendagli G
    Cancer Immunol Immunother; 2021 Jan; 70(1):75-87. PubMed ID: 32632664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
    Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
    J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
    Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
    Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of myeloid-derived suppressor cells in the peripheral blood and its clinical significance in renal carcinoma].
    Feng S; Liu C; Zheng S; Huang P; Chen B; Guo K
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):550-3. PubMed ID: 23644118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive activity enhances central carbon metabolism and bioenergetics in myeloid-derived suppressor cells in vitro models.
    Hammami I; Chen J; Murschel F; Bronte V; De Crescenzo G; Jolicoeur M
    BMC Cell Biol; 2012 Jul; 13():18. PubMed ID: 22762146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophages are more potent immune suppressors ex vivo than immature myeloid-derived suppressor cells induced by metastatic murine mammary carcinomas.
    Hamilton MJ; Bosiljcic M; Lepard NE; Halvorsen EC; Ho VW; Banáth JP; Krystal G; Bennewith KL
    J Immunol; 2014 Jan; 192(1):512-22. PubMed ID: 24285836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell proliferation and CD11b expression are controlled independently during HL60 cell differentiation initiated by 1,25 alpha-dihydroxyvitamin D(3) or all-trans-retinoic acid.
    Drayson MT; Michell RH; Durham J; Brown G
    Exp Cell Res; 2001 May; 266(1):126-34. PubMed ID: 11339831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The number of myeloid-derived suppressor cells in the peripheral blood and tumor tissues in patients with gastric cancer and its clinical significance].
    Xia R; Wang F; Gao T; Wen W; Lu B; Zhu Y; Zhang X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):740-3. PubMed ID: 25001941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Signature Differentiating Neutrophils and Myeloid-Derived Suppressor Cells Determined Using a Human Isogenic Cell Line Model and Protein Profiling.
    Zhang Y; Hu J; Zhang X; Liang M; Wang X; Gan D; Li J; Lu X; Wan J; Feng S; Lu X
    Cells; 2024 May; 13(10):. PubMed ID: 38786019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In whole blood, LPS, TNF-alpha and GM-CSF increase monocyte uptake of 99mtechnetium stannous colloid but do not affect neutrophil uptake.
    Ramsay SC; Maggs J; Powell K; Barnes J; Ketheesan N
    Nucl Med Biol; 2006 Jul; 33(5):645-51. PubMed ID: 16843839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.